Developing a faster and more versatile PCR method for DNA and RNA testing
Rapid, versatile PCR
This study is working on a new, faster, and more portable machine to help doctors quickly test for infections like the flu by improving how we copy DNA and RNA, so patients can get their results in just minutes instead of hours.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Numentus Technologies INC. NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-10822555 on NIH RePORTER |
What this research studies
This research focuses on improving the Polymerase Chain Reaction (PCR) technique, which is essential for amplifying DNA and RNA sequences. The goal is to create a new PCR instrument that is not only faster but also more versatile and portable than current models. By utilizing advanced optical heating methods, the research aims to reduce the time required for testing from hours to minutes, making it more efficient for diagnosing infections like influenza and other diseases. Patients may benefit from quicker and more accurate diagnostic results, which can lead to timely treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who require rapid diagnostic testing for viral infections, such as influenza.
Not a fit: Patients with conditions that do not require molecular diagnostic testing or those who are not affected by viral infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time it takes to diagnose infections, leading to faster treatment and better patient outcomes.
How similar studies have performed: Previous advancements in PCR technology have shown promise, particularly during the COVID-19 pandemic, indicating that this approach has the potential for success.
Where this research is happening
Menlo Park, United States
- Numentus Technologies INC. — Menlo Park, United States (Active)
Researchers
- Principal investigator: Faris, Gregory W — Numentus Technologies INC.
- Study coordinator: Faris, Gregory W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.